Concentrix Corporation

NASDAQ:CNXC

47.33 (USD) • At close April 17, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 2,372.2222,448.0242,387.4122,380.7162,402.7482,230.7621,632.8341,614.7061,636.4041,640.7181,579.6021,568.1011,536.0521,466.6081,397.2511,369.8781,353.2781,300.8581,163.6931,066.3621,188.621,212.8361,160.9281,160.8771,173.271
Cost of Revenue 1,516.3231,577.4271,523.221,699.5191,730.7331,407.9051,039.1421,034.4811,055.2431,047.3531,012.7541,009.185997.918947.24915.91887.149867.228842.226751.161721.193743.429754.405734.747730.35739.962
Gross Profit 855.899870.597864.192681.197672.015822.857593.692580.225581.161593.365566.848558.916538.134519.368481.341482.729486.05458.632412.532345.169445.191458.431426.181430.527433.309
Gross Profit Ratio 0.3610.3560.3620.2860.280.3690.3640.3590.3550.3620.3590.3560.350.3540.3440.3520.3590.3530.3550.3240.3750.3780.3670.3710.369
Reseach & Development Expenses 0000000000000000000000000
General & Administrative Expenses 0000000000000000000000000
Selling & Marketing Expenses 0000000000000000000000000
SG&A 687.032726.061710.95499.458493.98642.41431.425417.659425.114415.375409.303402.004390.389361.463329.962354.505351.161338.425335.77321.59356.979356.977346.956352.551345.201
Other Expenses 00019.4156.824-32.829-6.169-9.383-3.71412.6412.0862.5457.6160.7445.8583.546-3.8033.164-0.5931.6413.235-0.401000
Operating Expenses 687.032726.061710.95499.458493.98642.41431.425417.659425.114415.375409.303402.004390.389361.463329.962354.505351.161338.425335.77321.59356.979356.977353.706367.683373.069
Operating Income 168.867144.536153.242181.739178.035180.447162.267162.56674.898112.22691.19780.85181.268157.905151.379128.224134.889120.20776.76323.5888.211101.45479.22577.97688.108
Operating Income Ratio 0.0710.0590.0640.0760.0740.0810.0990.1010.0460.0680.0580.0520.0530.1080.1080.0940.10.0920.0660.0220.0740.0840.0680.0670.075
Total Other Income Expenses Net -68.075-31.63-126.826-63.042-75.615-103.337-55.462-56.596-37.704-15.421-8.186-10.428-1.154-2.9860.99-3.199-11.506-5.634-9.595-11.287-14.35-20.627-22.719-23.12-23.45
Income Before Tax 100.792112.90626.41687.12872.82477.11106.805105.97118.343162.569149.359146.484146.591154.919152.369125.025123.383114.57367.16812.29373.86180.82747.30639.14237.141
Income Before Tax Ratio 0.0420.0460.0110.0370.030.0350.0650.0660.0720.0990.0950.0930.0950.1060.1090.0910.0910.0880.0580.0120.0620.0670.0410.0340.032
Income Tax Expense 30.535-2.7449.78520.29420.7227.62329.1727.1230.47357.62542.23533.45136.05230.81142.61542.12134.57249.94621.7719.82321.54448.95716.97517.9033.417
Net Income 70.257115.6516.63166.83452.10269.48777.63578.8587.87104.944106.69113.142110.273124.108109.75482.90488.81164.62745.3972.4752.31731.8730.33121.23933.724
Net Income Ratio 0.030.0470.0070.0280.0220.0310.0480.0490.0540.0640.0680.0720.0720.0850.0790.0610.0660.050.0390.0020.0440.0260.0260.0180.029
EPS 1.04-2.010.250.980.761.11.51.511.692.022.082.192.122.372.11.591.721.250.880.0481.010.620.5880.4120.654
EPS Diluted 1.1-20.250.980.761.091.491.511.682.012.072.182.122.352.081.571.691.250.880.0481.010.620.5870.4110.652
EBITDA 168.867357.745283.351358.111362.54985.735259.339248.732241.006-40.503251.731238.034222.27-49.916218.52199.048202.131210.537144.51291.763160.24193.572153.903156.991166.119
EBITDA Ratio 0.0710.1460.1190.150.1510.0380.1590.1540.147-0.0250.1590.1520.145-0.0340.1560.1450.1490.1620.1240.0860.1350.160.1330.1350.142